Home / Share Price Target / Syncomf
Syncom Formulations Share Price Target 2024, 2025, 2026 to 2039 With Charts
Syncom Formulations | |||
 | Symbol: SYNCOMF | ||
| Price: ₹20.18 | |||
| Exchange: NSE | |||
| Healthcare -> Drug Manufacturers - Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: Syncom Formulations Brief Company Overview
- 1.1: Syncom Formulations (India) Limited: A Trusted Pharmaceutical Manufacturer
- 1.2: Syncom Formulations Financial Performance
- 1.2.1: Is Syncom Formulations A Good Buy For Long Term?
- 2: Approach 1: Technical Analysis Paired With Price Action
- 2.1: Syncom Formulations Share Price Target For 2024
- 2.1.1: Syncom Formulations Share Price Target Table For 2024
- 2.1.2: Summary: Syncom Formulations Share Price Prediction For 2024
- 2.2: Syncom Formulations Share Price Target For 2025
- 2.2.1: Syncom Formulations Share Price Target Table For 2025
- 2.2.2: Summary: Syncom Formulations Share Price Prediction For 2025
- 3: Approach 2: Machine Learning By Studying Historical Prices
- 3.1: Syncom Formulations Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 3.2: Syncom Formulations Share Price Target Table From 2024, 2025, 2026 to 2039
- 4: Syncom Formulations Past Performance
Syncom Formulations Brief Company Overview
Syncom Formulations (India) Limited: A Trusted Pharmaceutical Manufacturer
Syncom Formulations (India) Limited, established in 1988, is a leading pharmaceutical manufacturer headquartered in Indore, India. The company boasts a diverse product portfolio that includes antibiotics, anthelmintics, cardiac, derma, and pediatrics formulations.
Syncom's commitment to quality and innovation has earned it a strong reputation in the industry. Its pharmaceutical formulations are available in various dosage forms, catering to a wide range of therapeutic needs. The company also engages in commodity trading and property renting.
- Key Products: Pharmaceutical formulations, antibiotics, anthelmintics, cardiac, derma, gastro, gynae, opthal, ortho, and pediatrics formulations
- Services: Trading of commodities, renting of properties
- Market Presence: Exports products to various countries
Syncom Formulations Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 1,263.35 Crore | Market valuation of Syncom Formulations's shares. |
| Revenue (TTM) | 249.79 Crore | Total revenue generated by Syncom Formulations over the past twelve months. |
| Net Income (TTM) | +26.38 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | 9.07% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 10.56% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) | +13.5% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) | +68.89% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio | 29.64 | Company's total debt divided by total shareholder equity. |
| Total Debt | 80.08 Crore | Sum of Syncom Formulations's current & long-term financial obligations. |
| Total Cash | 61.38 Crore | Total amount of liquid funds available to Syncom Formulations. |
| Beta | 1.27 | Beta is greater than 1 indicating that the Syncom Formulations's price is more volatile than the market. |
Is Syncom Formulations A Good Buy For Long Term?
Syncom Formulations, a small-cap stock with a market cap of 1,224.82 Crore, has shown promising growth in the last 12 months, generating a revenue of 249.79 Crore and a net profit of 26.38 Crore. Its strong revenue and earnings growth, along with healthy margins, indicate potential for long-term growth. Despite a current debt of 80.08 Crore, the company's cash balance of 61.38 Crore provides financial stability. Investors looking for a long-term investment opportunity in the pharmaceuticals sector may consider Syncom Formulations.
To predict the Syncom Formulations's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Syncom Formulations Share Price Target For 2024
The line chart displays the monthly closing prices of Syncom Formulations with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Syncom Formulations shares in 2024, see the table below.
Syncom Formulations Share Price Target Table For 2024
| Syncom Formulations's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 20.82 (+3.17%) | Price Action: 16 Oct 2024 Low |
| 2024 Target 2 | 20.60 (+2.08%) | Price Action: Oct 2024 High |
| 2024 Target 1 | 20.32 (+0.69%) | Price Action: 17 Oct 2024 Low |
| Current Price | 20.18 | Syncom Formulations's 1 share price as of Tue 19 Nov 2024 |
| Stop Loss 1 | 20.11 (-0.35%) | Price Action: Chart |
| Stop Loss 2 | 19.89 (-1.44%) | Price Action: 29 Oct 2024 High |
| Stop Loss 3 | 19.67 (-2.53%) | Fibonacci Retracement Extended 40% |
Summary: Syncom Formulations Share Price Prediction For 2024
In summary, Syncom Formulations has surged by ₹5.13, achieving a notable +34.09% increase from 1st January 2024 to 19 Nov 2024. Our analysis of Syncom Formulations for 2024 predicts an additional rise of 0.69% to 3.17% by the end of 2024 with three potential targets T1: 20.32, T2: 20.60, T3: 20.82. Stop Loss at SL1: 20.11, SL2: 19.89, SL3: 19.67.
Syncom Formulations has a 52-week high of ₹27.90, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹9.80, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Syncom Formulations.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Syncom Formulations Share Price Target For 2025
The line chart displays the monthly closing prices of Syncom Formulations with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Syncom Formulations shares in 2025, see the table below.
Syncom Formulations Share Price Target Table For 2025
| Syncom Formulations's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 30.15 (+49.4%) | Price Action: Chart |
| 2025 Target 2 | 29.59 (+46.63%) | Price Action: Chart |
| 2025 Target 1 | 29.30 (+45.19%) | Custom Fibonacci Extension Lvl 64.9% |
| Current Price | 20.18 | Syncom Formulations's 1 share price as of Tue 19 Nov 2024 |
| Stop Loss 1 | 18.02 (-10.71%) | Price Action: 25 Oct 2024 Low |
| Stop Loss 2 | 17.84 (-11.6%) | Price Action: Chart |
| Stop Loss 3 | 17.52 (-13.19%) | Price Action: Chart |
Summary: Syncom Formulations Share Price Prediction For 2025
In summary, Syncom Formulations has surged by ₹5.13, achieving a notable +34.09% increase from 1st January 2024 to 19 Nov 2024. Our analysis of Syncom Formulations for 2025 predicts an additional rise of 45.19% to 49.4% by the end of 2025 with three potential targets T1: 29.30, T2: 29.59, T3: 30.15. Stop Loss at SL1: 18.02, SL2: 17.84, SL3: 17.52.
Syncom Formulations has a All-Time high of ₹27.90, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹9.80, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Syncom Formulations, we have created a specific page for that check here: Syncom Formulations Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Syncom Formulations Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Syncom Formulations share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 16.68% over the next 15 years.
For complete year by year Syncom Formulations long term share price target from 2024, 2025 to 2039 check the below table.
Syncom Formulations Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | Syncom Formulations Target | YoY Change % |
|---|---|---|
| 2024 | ₹20.18 | [Current Price] |
| 2024 | ₹22.68 | 12.38% |
| 2025 | ₹36.15 | 59.43% |
| 2026 | ₹48.5 | 34.12% |
| 2027 | ₹66.64 | 37.4% |
| 2028 | ₹77.02 | 15.57% |
| 2029 | ₹85.39 | 10.86% |
| 2030 | ₹100.54 | 17.74% |
| 2031 | ₹112.16 | 11.55% |
| 2032 | ₹135.94 | 21.2% |
| 2033 | ₹143.31 | 5.42% |
| 2034 | ₹148.1 | 3.34% |
| 2035 | ₹164.92 | 11.35% |
| 2036 | ₹175.83 | 6.61% |
| 2037 | ₹205.23 | 16.72% |
| 2038 | ₹209.61 | 2.13% |
| 2039 | ₹196.66 | -6.18% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Syncom Formulations Past Performance
- In 2006, Syncom Formulations opening price was ₹1.1
- As of Tue 19 Nov 2024 the price stands at ₹20.18.
- This represents a Compound Annual Growth Rate (CAGR) of 16.55%.
- In 18 years, an investment of 10,000 would have become ₹1.83 Lakh.
As we wrap up, we hope you like our study on Syncom Formulations share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
